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Abstract The effect of DNA methylation upon posttranscrip-
tional gene silencing (PTGS) has been investigated in transgenic
tobacco lines showing PTGS and methylation of the neomycin
phosphotransferase II (nptII) reporter genes. Application of the
hypomethylation drugs dihydroxypropyladenine or 5-azacytidine
resulted in approximately 30% reduced methylation of cytosines
located in a non-symmetrical context in the 3P untranslated
region of the nptII transgenes. The hypomethylation was
accompanied by up to 12-fold increase in NPTII protein levels,
suggesting that methylation of non-symmetrical motifs may
account for an increased degree of PTGS. Models for the
possible role of DNA methylation in PTGS are discussed.
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1. Introduction
In plants, the posttransriptional gene silencing (PTGS) pro-
cess is characterized by several features, including normal
transcriptional activity of the promoter, RNA instability,
the capacity to degrade homologous RNA from unlinked
loci, and meiotic resetting (for review, see [1]). At the DNA
level, silenced transgenes often possess a high level of cytosine
methylation, particularly in the 3P half of the transcribed re-
gion [2^4]. Methylation modi¢cation in the promoter region
has been convincingly shown to be incompatible with tran-
scription in vitro [5] and in vivo [6]. In vivo induced DNA
hypomethylation by drug treatment or in particular genetic
backgrounds leads almost in every case to activation of gene
expression in both mammals [7] and plants [8^11], suggesting
a causal relationship between transcription inhibition and pro-
moter methylation. However, despite the good correlation be-
tween coding sequence methylation and reduction of steady-
state mRNA levels, especially in transgenes with no homolo-
gous endogenes [1^3], the precise role of methylation in PTGS
has not been established yet. In particular, it is not known
whether DNA methylation is required to trigger and maintain
silencing or whether this epigenetic modi¢cation is merely an
outcome of silenced state established by other mechanisms.
The evidence to distinguish between these two possibilities is
often con£icting. The early appearance of methylation preced-
ing the onset of silencing in virus-induced PTGS suggests
rather a more active involvement of DNA methylation, at
least in some cases of PTGS [12]. On the other hand, cosup-
pression (silencing of homologous endogenous gene by a
transgene) occurs in some cases without extensive methylation
of homologous endogenous sequences arguing against the pri-
mary role of DNA methylation in silencing triggering [13^15].
In Neurospora, the PTGS-related gene silencing in the vegeta-
tive phase is called ‘quelling’ and was shown to be methyla-
tion independent [16]. In the same organism, premature tran-
scription termination caused by methylation of transcribed
sequences resulted in reduced steady-state RNA levels of
genes a¡ected by repeat-induced point mutation [17]. Whether
both methylation-dependent and -independent silencing sys-
tems occur in plants is not determined yet.
Previously, we have elaborated a system to inhibit DNA
methyltransferase through the accumulation of the S-adeno-
sylhomocysteine (SAH) metabolite, a natural inhibitor of
transmethylation reactions. Application of (S)-9-(2,3-dihy-
droxypropyl)adenine (DHPA), a competitive inhibitor of
SAH-hydrolase in tobacco cell cultures led to the dramatic
accumulation of intracellular SAH [18] together with hypo-
methylation of repetitive sequences in tobacco and this with
considerable speci¢city for CNG [19] and non-symmetrical
motifs [20]. Also transgenic tobacco plants that expressed
antisense SAH-hydrolase showed an increased accumulation
of SAH and a hypomethylated genome [21]. The commonly
used 5-azacytidine inhibits methylation because it is incorpo-
rated into DNA instead of cytosine and then covalently binds
and inactivates enzyme molecules [22]. Therefore, 5-azacyti-
dine incorporation has an e¡ect on both symmetrical and
non-symmetrical cytosines. Combination of two hypomethyl-
ation drugs with a di¡erent mode of action, 5-azacytidine and
DHPA, o¡ers a suitable tool to study methylation-dependent
expression of genes under the limiting DNA methyltransferase
activities.
We have previously characterized several tobacco transgen-
ic lines carrying the neomycin phosphotransferase II (nptII)
reporter gene [3,23,24]. Up to 1000-fold di¡erences in expres-
sion of nptII were found between individual genotypes [23].
Nuclear run-on assays con¢rmed that silencing occurred at
the posttranscriptional level [3,24] and that only transcribed
sequences seemed to possess silencing capacities in trans [25].
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DNA methylation of both symmetrical and non-symmetrical
motifs was speci¢cally found in the 3P end of the silenced nptII
gene [3,4,23] and the degree of methylation correlated with
changes in RNA synthesis levels during plant development
[23]. Here, we assess the role of DNA methylation in PTGS
through the experimentally induced hypomethylation in cell
cultures of silenced transgenic tobacco lines.
2. Materials and methods
2.1. Plant material and culture conditions
Callus cell cultures were established from leaf explants by hormonal
treatment according to standard procedures. Calluses were grown in
0.7% agar containing B5 salts supplemented with sucrose (30 g/l),
K-naphthaleneacetic acid (2.0 mg/l), and 6-benzylaminopurine (0.2
mg/l). The drug treatments were performed on fully undi¡erentiated
cells following continuous passage in culture for more than 90 days.
The hypomethylation schemes were as follows: the cells were grown in
the presence of 25 WM and 100 WM DHPA for 4^5 weeks, or in the
presence of 200 WM 5-azacytidine for 6^8 weeks. DHPA was synthe-
sized by organic synthesis according to the method described in [26].
2.2. DNA isolation and Southern blot hybridization
Total genomic DNA was extracted from approximately 10 g of wet
callus tissue according to the modi¢ed procedure of Saghai-Maroof et
al. [27]. Calluses were extensively lyophilized prior to homogenization
in liquid nitrogen. After isopropanol precipitation, DNA was dis-
solved and subjected to RNase A (40 Wg/ml, 15 min, 37‡C) and pro-
teinase K (20 Wg/ml, 2 h, 50‡C) treatments, extracted using phenol-
chloroform-isoamylalcohol (25:24:1) and chloroform-isoamylalcohol
(24:1), and precipitated with ethanol. The quantity and quality of
DNA preparations were checked by absorbance at 260/280 nm.
Puri¢ed DNA was digested with an excess of enzyme (5 U/Wg
DNA) added at two 3-h intervals to the reaction mixture. Approx-
imately 10^15 Wg of digested DNA was loaded on gel, electrophoresed
in a 0.8% agarose gel and alkali-blotted onto Hybond XL membrane
(Amersham, Aylesbury, UK). The DNA on ¢lters was hybridized
with a 32P-labelled DNA probe (DekaLabel kit, MBI, Fermentas,
Vilnius, Lithuania) corresponding to the entire NPTII-coding se-
quence (a 0.8-kb BglII/BamHI fragment). Southern hybridization
was carried out in 0.25 M Na-phosphate bu¡er, pH 7.0, supplemented
with 7% sodium dodecyl sulfate (SDS) at 65‡C for 16 h followed by
washing with 2USSC (1USSC, 150 mM NaCl, 15 mM Na3-citrate,
pH 7.0), 0.1% SDS (twice 5 min), 0.2USSC, 0.1% SDS (twice 15 min).
Completion of digests was checked by hybridization with a chloro-
plast probe. The hybridization bands were visualized by phosphor-
imaging (Molecular Dynamics, Sunnyvale, CA, USA) overnight and
autoradiography (1^2 weeks exposure). Quanti¢cation of hybridiza-
tion signals was performed by ImageQuant software (Molecular Dy-
namics).
2.3. Protein extraction and NPTII ELISA
To extract soluble proteins, the lyophilized callus tissue (20^40 mg
of dry weight) was ground in an Eppendorf tube with 200^400 Wl
extraction bu¡er (0.25 M Tris^HCl, pH 8.0, 1 mM phenylmethylsul-
fonyl£uoride), then centrifuged at 20 000Ug to remove cell debris.
The protein concentration of the extracts was determined according
to the Bio-Rad (Hercules, CA, USA) protein assay [28]. The NPTII
ELISA was done according to the manufacturer’s instructions
(5 PrimeC3 Prime, Boulder, CO, USA). Reading of the microtiter
plate was done at 405 nm, using a kinetic program (5-min intervals for
2 h).
3. Results
3.1. Plant material
The three transgenic tobacco lines used to examine the re-
lationship between methylation and PTGS are descendants of
the primary transformant pGVCHS(287) [25]. The transgenic
T-DNA construct contained the nptII reporter gene under
control of the 35S cauli£ower mosaic virus promoter. The
characteristics of individual lines were as follows: in the line
hemizygous for locus 1 (HElo1) two T-DNAs were integrated
as an inverted repeat (designated locus 1) [25]; the nptII gene
was highly methylated in the transcribed region and its ex-
pression was close to the background values [4]. In the line
hemizygous for locus 2 (HElo2), the T-DNA was integrated
as a single copy insertion (locus 2), no methylation was found
within the restriction sites investigated and the nptII gene was
highly expressed [4]. The HElo1/HElo2 hybrid line carrying
both loci was obtained by crossing homozygous locus 1
(HOlo1) and homozygous locus 2 (HOlo2) lines and displayed
strong locus 1-dependent silencing of the nptII gene expression
from locus 2 [24]. The structure of the silencing locus 1
present in HElo1 and HElo1/HElo2 lines is depicted in Fig.
1 [25]. To inhibit DNA methyltransferase activity and conse-
quently DNA methylation, callus cultures and the two hypo-
methylation drugs, DHPA and 5-azacytidine, were used. The
methylation pattern and gene expression of the nptII trans-
genes were not grossly in£uenced by callus induction (data not
shown).
3.2. Drug-induced hypomethylation of cytosines within the
coding region of the nptII transgene
Callus cultures derived from the silenced (HElo1, HElo1/
HElo2) and non-silenced (HElo2) transgenic lines were treated
with 25 WM and 100 WM DHPA or with 200 WM 5-azacytidine
(see Section 2). The extent of DNA hypomethylation was
investigated within a 11-bp sequence located in the 3P untrans-
lated region of the transcribed region. At position +876/886
(relative to the transcription starting site) and 33 bp down-
stream of the nptII-coding sequence and 219 bp upstream of
the polyadenylation site, this sequence contained the recogni-
tion sequences for BamHI and SmaI methylation-sensitive re-
striction enzymes. DNA from the highly expressing cell line
HElo2, which does not show methylation of BamHI or SmaI
sites, served as a control.
From the nptII sequence (Fig. 1), it follows that two meth-
Fig. 1. Physical map of the BamHI (B) and SmaI (S) sites in the
silencing locus 1. Evidence for an inverted repeat character of the
T-DNA insertion is given elsewhere [5]. The sequence context of the
BamHI site between the nptII-coding region and 3Pchs untranslated
region is shown to demonstrate the non-symmetrical position of
methylation-sensitive cytosines within the site (underlined). The size
of the diagnostic fragments for digestion at +876 (BamHI) and
+881 (SmaI) of the nptII gene are illustrated below. LB, T-DNA
left border; RB, T-DNA right border; P35S, 35S promoter of cauli-
£ower mosaic virus; 3Pchs, 3P chalcone synthase untranslated region
from Antirrhinum majus.
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ylation-sensitive cytosines, one on each DNA strand within
the BamHI site, are located in non-symmetrical contexts.
The hybridizing BamHI fragments obtained with an nptII-
coding sequence probe in digested DNA from the non-si-
lenced HElo2 line yielded a 2.5-kb hybridization fragment
corresponding with the predicted size for the non-methylated,
completely restricted DNA. However, upon methylation hy-
bridizing bands originating from DNA molecules with two,
one, and no methylated BamHI sites (bands of 6.2, 3.7, and
2.5 kb, respectively; Fig. 1) can be visualized in lanes loaded
with DNA isolated from HElo1 and HElo1/HElo2 cells. In
control digests of HElo1 and HElo1/HElo2 DNAs isolated
from calluses that were not treated with hypomethylation
drugs, the 6.2-kb hybridization fragment always appeared as
the strongest band in electrophoretic pro¢les, suggesting
abundant methylation of both internal BamHI sites of the
inverted repeat (Fig. 2A). Reproducibly and signi¢cantly, di-
gestions of DNA samples from calluses treated with DHPA
(Fig. 2A and B) or 5-azacytidine (Fig. 2C) were more com-
plete, resulting in an increase of the intensity of the 2.5-kb
fragment. To quantify the extent of hypomethylation, we
measured the band intensities in individual lanes by a Phos-
phorImager. The digestibility of DNA (expressed as the
amount of the 2.5-kb band relative to the total signal) seemed
to be proportional to the concentration of DHPA in culture
media. At the highest concentration of DHPA (100 WM) used,
the methylation of the BamHI sites was reduced by 16% and
26% for HElo1 and HElo1/HElo2 lines, respectively (Fig. 2A).
The SmaI enzyme that recognizes the CCCGGG sequence
is sensitive to cytosine methylation at the symmetrical CG
motif [29]. The 2.5-kb hybridization fragment corresponds
to fully digested and non-methylated T-DNAs, whereas the
6.2-kb fragment indicates methylation of the SmaI site at the
3P end of the two nptII genes. The presence of the 6.2-kb band
and the absence of a 2.5-kb band in silenced genotypes (Fig.
2B) showed that the SmaI sites at +881 were completely meth-
ylated in virtually all the DNA molecules. Thus, the SmaI
sites were noticeably more methylated than the BamHI sites
probably because of the symmetrical distribution of the meth-
ylation-sensitive cytosines in a CG motif. Similarly to the
BamHI digests, no additional hybridizing DNA fragments
were visualized on the autoradiograph, indicating the absence
of methylation at the BamHI and SmaI sites in the 5P up-
stream sequences (Fig. 2B). In the samples treated with de-
methylating drugs, the enhanced SmaI cleavage was observed
only in DNA isolated from HElo1/HElo2 cells grown with
Fig. 3. NPTII protein accumulation levels in hypomethylated and
control samples. Protein extracts from drug-treated and non-treated
calluses were assayed for the NPTII protein content by ELISA. For
each experiment with cell cultures, two parallel samples were ana-
lyzed. Each protein extract was assayed by three independent ELI-
SAs and the results were expressed as an average.
Fig. 2. Evidence for hypomethylation of nptII-coding sequences induced by two di¡erent drugs. Gel blots of DNA from calluses treated with
DHPA (A and B) and 5-azacytidine (C). The methylation was analyzed by digestion of DNAs with BamHI (A, C) and SmaI (B). The blots
were hybridized with the nptII-coding region-speci¢c DNA probe. The extent of the digestions at +876 (BamHI) and +881 (SmaI) sites was
quantitated for each lane and is expressed as the percentage of the intensity of the 2.5-kb band relative to the sum of the 6.2-kb and 3.7-kb
bands by PhosphorImager analysis.
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100 WM DHPA, suggesting that the observed hypomethyla-
tion was derived from locus 2 on which methylation had been
imposed by the presence of locus 1 in a hybrid HElo1/HElo2
line [4].
3.3. Expression of the nptII reporter gene in hypomethylated
calluses
To assess the e¡ects of methylation associated with PTGS
genes, we analyzed the NPTII protein content in methylated,
hypomethylated, and non-methylated calluses. Protein ex-
tracts prepared from aliquots of the same callus tissue used
previously for DNA extraction were assayed for the NPTII
protein concentration using ELISA (Fig. 3). In untreated sam-
ples, the NPTII accumulation in the silenced genotypes HElo1
and HElo1/HElo2 was at least 200-fold lower than that in the
non-silenced HElo2 genotype. These values were similar to
those in leaf tissue [25]. The drug treatments resulted in ele-
vated accumulation levels of NPTII protein in the silenced
genotypes of HElo1 and HElo1/HElo2. When di¡erent con-
centrations of DHPA were tested, the NPTII content corre-
lated with the concentration of the applied drug and also with
the extent of hypomethylation of the BamHI site. The NPTII
accumulation levels in the non-silenced HElo2 genotype re-
mained essentially the same or were even slightly reduced after
the DHPA treatment. Together, both drugs that induced hy-
pomethylation by a di¡erent biochemical mechanism of DNA
methyltransferase inhibition, caused higher accumulation of
the protein product of a reporter gene. Therefore, we conclude
that hypomethylation of transcribed sequences can partially
release the established silencing by interfering either with the
creation of the silencing-inducing signal or with the mainte-
nance of an induced autocatalytic cycle.
4. Discussion
The results presented here indicate that methylation of tran-
scribed sequences plays a role in PTGS. When methylation of
the reporter nptII gene was partially inhibited either with
DHPA or 5-azacytidine, we observed a concentration-depen-
dent (6^12-fold) increase in the expression of silenced loci.
The methylation changes were monitored on a 11-bp se-
quence located at the 3P end of the nptII reporter gene en-
abling methylation analysis of both symmetrical (CG) and
non-symmetrical motifs lying next to each other. Application
of DHPA led to a rather speci¢c hypomethylation of non-
symmetrically methylated cytosines without major hypo-
methylation of symmetrical CG motifs con¢rming our pre-
vious experiments with this drug [19]. However, the extent
of hypomethylation of silent T-DNA loci was slightly lower
than in other parts of genome. For example, at 25 WM DHPA
some non-symmetrical sites within the 5S rRNA genes were
completely demethylated [20], whereas that within the BamHI
site of the T-DNA was hypomethylated by approximately
10%. In the HElo1 genotype, the symmetrical CG motif lo-
cated within the neighboring SmaI site was not hypometh-
ylated, even at the highest concentration of the inhibitor. In
highly methylated regions (for example, the 3P end of the nptII
genes in locus 1 [4]), the inhibition of methyltransferase activ-
ity resulted probably in an ordered hypomethylation of di¡er-
ent sequence motifs: hypomethylation of non-symmetrical
motifs before hypomethylation of symmetrical motifs. Inter-
estingly, such hierarchy of hypomethylation also seems to
hold true for genetically induced hypomethylation in Arabi-
dopsis in which ddm1-induced reduction of cytosine methyl-
ation levels resulted in activation of an endogenous gene fam-
ily [10]. Possibly de novo methylation (which needs to be
established after each replication cycle) of non-symmetrical
sites is sensitive to various stimuli including methyltransferase
cofactor levels whereas the maintenance of the methylation of
symmetrical sites could be more stable. In reminiscence, the
methylation of a non-symmetrical motif (also in a 3P located
BamHI site) correlated with observed developmental changes
in nptII gene expression in tobacco transgenic lines [23].
Whereas the 3P located SmaI sites in locus 1 remained hyper-
methylated, the SmaI site was hypomethylated to some extent
in a silenced locus 2 in drug-treated hybrid HElo1/HElo2
calluses. Also inspection of the less methylated 5P transcribed
region of the nptII gene in the HElo1 line revealed some
hypomethylated CG motifs (data not shown). The di¡erential
methylation (and hypomethylation) of the same restriction
sites located within locus 1 and locus 2 possibly re£ects di¡er-
ent methylation mechanisms of silencing and in trans-silenced
loci. The silenced locus 2 had a considerably lower degree of
methylation in the nptII-coding sequence compared to the
analogous region in locus 1 [4] and may be methylated by
RNA-directed methylation [30]. On the other hand, the exten-
sive methylation in locus 1 may be directed by the palindrom-
ic arrangement of the T-DNA insertion in which both RNA
[30] and DNA [15] methylation signals may be active.
Reduction of silencing can be correlated with the extent of
hypomethylation of cytosine residues located at the 3P end of
the gene. Control experiments in transgenic, non-silenced lines
showed a similar or slightly reduced nptII expression after the
drug treatments ruling out the possibility that global hypo-
methylation altered the expression of a putative 35S pro-
moter-activating transcription factor. The possible hypo-
methylation of promoter sequences did probably not
contribute to elevated expression because the methylation of
the 5P upstream sequences of posttranscriptionally silenced
nptII genes was low or negligible [23]. It is necessary to stress
that in our system the drug-induced hypomethylation did not
increase the expression of the silenced reporter gene to the
level seen in non-silenced lines. In fact, the 10-fold increased
NPTII protein levels observed in silenced lines after hypo-
methylation induction correspond to approximately 10% of
the NPTII protein levels found in non-silenced lines. This
observation may be explained by the fact that only partial
hypomethylation of the gene was achieved by drug treatments
(most CG sites were not hypomethylated). Another possibility
is that additional epigenetic mechanisms besides methylation
a¡ect and regulate the maintenance of the sequence-speci¢c
PTGS. However, hypomethylation of CNG motifs without
concomitant hypomethylation of CG sites has been observed
in activated transgenes of Arabidopsis mutated in the sgs1-1
locus [31], suggesting that partial hypomethylation may be
enough to trigger complete or partial expression. The e¡ect
of hypomethylating drugs on gene expression was more pro-
nounced in a hybrid genotype than in that with the silencer
locus alone, what may be related to less extensive methylation
of silenced locus 2 and/or to weakening of the silencing signal
induced by locus 1.
Most intriguing is what might be the mechanism linking
RNA degradation and DNA methylation. Transient transfec-
tion experiments in tobacco protoplasts using in vitro meth-
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ylated constructs showed inhibition of transcription elonga-
tion by methylation of the coding sequences [32]. In Neuro-
spora, Rountree and Selker [17] elegantly showed inhibition of
RNA elongation along DNA that contained nearly every cy-
tosine methylated. The elongation block could be relieved by
5-azacytidine or by a mutation a¡ecting the metabolism of
methylation cofactors. The above described plant system
shares apparent similarities with that in Neurospora : (i) silenc-
ing is induced posttranscriptionally, (ii) partial relief of silenc-
ing can be induced with hypomethylation drugs, and (iii) 3P
ends of transcribed sequences have an extremely high density
of methylation located on both symmetrical and non-symmet-
rical cytosines. Adapting Selker’s model, we propose that
RNA elongation may slow down at the 3P end either because
of di⁄culties of the RNA polymerase machinery to get
through methylated cytosines or more probably through a
condensed chromatin that is possibly assembled on methylat-
ed DNA [33]. A decreased rate of elongation may result in
‘jamming’ of RNA molecules that are already present on the
DNA at a high density because of frequent initiation of tran-
scription by the strong 35S promoter. Decreased spacing be-
tween ‘jammed’ RNA molecules along the DNA would favor
formation of intermolecular (rather than normal intramolec-
ular) bonds between individual RNA molecules. Complexes of
several RNA molecules might be recognized by cellular de-
fence systems as ‘aberrant’ and consequently degraded [34].
Another and equally probable possibility is that transcription
through densely methylated DNA regions interferes with the
folding and processing of the pre-RNA. By doing so, incor-
rectly assembled or inverted repeat readthrough RNAs can
accumulate generating the molecular signals for PTGS estab-
lishment. A third possibility is that methylation induces con-
formational chromatin changes and that the resulting hetero-
chromatin might recruit an RNA degradation machinery to
the target locus. Short RNA molecules formed as an outcome
of degradation process or other aberrant RNAs may subse-
quently serve as templates for an RNA-dependent RNA poly-
merase [35] and initiate degradation of any homologous mol-
ecule in trans by a process that could already be methylation
independent. Further studies will be needed to characterize
the chromatin structures at the inverted repeat center and
establish the role of DNA methylation in maintaining an in-
active state.
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